Finland
Tuberculosis profile
Population  2012 5.4 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.015 (0.015–0.015) 0.29 (0.28–0.29)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0 (0–0)
Prevalence  (includes HIV+TB) 0.39 (0.13–0.79) 7.2 (2.4–15)
Incidence  (includes HIV+TB) 0.3 (0.26–0.34) 5.5 (4.9–6.3)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.02–0.02)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 78 (31) Relapse 5 (28)
Smear-negative 90 (36) Treatment after failure 0 (0)
Smear-unknown / not done 14 (6) Treatment after default 0 (0)
Extrapulmonary 70 (28) Other 13 (72)
Other 0 (0)      
Total new 252   Total retreatment 18  
           
Other (history unknown) 4        
Total new and relapse 257   Total cases notified 274  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.1 1.7 0.7
Age < 15 1 3 1
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 67   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 3  
Retreatment 25  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.5 (0.3–4.2) 0 (0–23)
MDR-TB cases among notified pulmonary
TB cases
3 (1–8) 0 (0–4)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 206 (99%) 14 (78%) 222
Laboratory-confirmed MDR-TB cases 3 0 3
Patients started on MDR-TB treatment     3
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data